| Creation of human tumour cells with defined genetic elements WC Hahn, CM Counter, AS Lundberg, RL Beijersbergen, MW Brooks, ... Nature 400 (6743), 464-468, 1999 | 3069 | 1999 |
| hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization M Meyerson, CM Counter, EN Eaton, LW Ellisen, P Steiner, SD Caddle, ... cell 90 (4), 785-795, 1997 | 2588 | 1997 |
| Unresponsiveness of colon cancer to BRAF (V600E) inhibition through feedback activation of EGFR A Prahallad, C Sun, S Huang, F Di Nicolantonio, R Salazar, D Zecchin, ... Nature 483 (7387), 100-103, 2012 | 2162 | 2012 |
| A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancer K Berns, HM Horlings, BT Hennessy, M Madiredjo, EM Hijmans, K Beelen, ... Cancer cell 12 (4), 395-402, 2007 | 1876 | 2007 |
| A large-scale RNAi screen in human cells identifies new components of the p53 pathway K Berns, EM Hijmans, J Mullenders, TR Brummelkamp, A Velds, ... Nature 428 (6981), 431-437, 2004 | 1468 | 2004 |
| Inhibition of telomerase limits the growth of human cancer cells WC Hahn, SA Stewart, MW Brooks, SG York, E Eaton, A Kurachi, ... Nature medicine 5 (10), 1164-1170, 1999 | 1394 | 1999 |
| Reversible and adaptive resistance to BRAF (V600E) inhibition in melanoma C Sun, L Wang, S Huang, GJJE Heynen, A Prahallad, C Robert, ... Nature 508 (7494), 118-122, 2014 | 880 | 2014 |
| Dissociation among in vitro telomerase activity, telomere maintenance, and cellular immortalization CM Counter, WC Hahn, W Wei, SD Caddle, RL Beijersbergen, ... Proceedings of the National Academy of Sciences 95 (25), 14723-14728, 1998 | 833 | 1998 |
| Statistical methods for analysis of high-throughput RNA interference screens A Birmingham, LM Selfors, T Forster, D Wrobel, CJ Kennedy, E Shanks, ... Nature methods 6 (8), 569-575, 2009 | 668 | 2009 |
| Stabilization of N-Myc is a critical function of Aurora A in human neuroblastoma T Otto, S Horn, M Brockmann, U Eilers, L Schüttrumpf, N Popov, ... Cancer cell 15 (1), 67-78, 2009 | 620 | 2009 |
| Phosphatidylinositol 3-kinase hyperactivation results in lapatinib resistance that is reversed by the mTOR/phosphatidylinositol 3-kinase inhibitor NVP-BEZ235 PJA Eichhorn, M Gili, M Scaltriti, V Serra, M Guzman, W Nijkamp, ... Cancer research 68 (22), 9221-9230, 2008 | 585 | 2008 |
| The ubiquitin-specific protease USP28 is required for MYC stability N Popov, M Wanzel, M Madiredjo, D Zhang, R Beijersbergen, R Bernards, ... Nature cell biology 9 (7), 765-774, 2007 | 552 | 2007 |
| E2F-4, a new member of the E2F gene family, has oncogenic activity and associates with p107 in vivo. RL Beijersbergen, RM Kerkhoven, L Zhu, L Carlée, PM Voorhoeve, ... Genes & development 8 (22), 2680-2690, 1994 | 481 | 1994 |
| MED12 controls the response to multiple cancer drugs through regulation of TGF-β receptor signaling S Huang, M Hölzel, T Knijnenburg, A Schlicker, P Roepman, U McDermott, ... Cell 151 (5), 937-950, 2012 | 478 | 2012 |
| CRISPR knockout screening outperforms shRNA and CRISPRi in identifying essential genes B Evers, K Jastrzebski, JPM Heijmans, W Grernrum, RL Beijersbergen, ... Nature biotechnology 34 (6), 631-633, 2016 | 449 | 2016 |
| Regulation of the retinoblastoma protein-related p107 by G1 cyclin complexes. RL Beijersbergen, L Carlée, RM Kerkhoven, R Bernards Genes & development 9 (11), 1340-1353, 1995 | 369 | 1995 |
| Intracellular bacterial growth is controlled by a kinase network around PKB/AKT1 C Kuijl, NDL Savage, M Marsman, AW Tuin, L Janssen, DA Egan, ... Nature 450 (7170), 725-730, 2007 | 368 | 2007 |
| E2F-5, a new E2F family member that interacts with p130 in vivo EM Hijmans, PM Voorhoeve, RL Beijersbergen, LJ van't Veer, R Bernards Molecular and cellular biology, 1995 | 351 | 1995 |
| Intrinsic resistance to MEK inhibition in KRAS mutant lung and colon cancer through transcriptional induction of ERBB3 C Sun, S Hobor, A Bertotti, D Zecchin, S Huang, F Galimi, F Cottino, ... Cell reports 7 (1), 86-93, 2014 | 345 | 2014 |
| A genetic screen identifies PITX1 as a suppressor of RAS activity and tumorigenicity IGM Kolfschoten, B van Leeuwen, K Berns, J Mullenders, ... Cell 121 (6), 849-858, 2005 | 336 | 2005 |
